Search

Your search keyword '"Furukawa, Yutaka"' showing total 1,318 results

Search Constraints

Start Over You searched for: Author "Furukawa, Yutaka" Remove constraint Author: "Furukawa, Yutaka"
1,318 results on '"Furukawa, Yutaka"'

Search Results

202. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke

203. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

204. Serum cholinesterase as a prognostic biomarker for acute heart failure

206. Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study

207. C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study

215. Mechanism of improvement in atrial functional mitral regurgitation after catheter ablation for atrial fibrillation: Three‐dimensional analysis using multislice computed tomography.

224. Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk

226. Impact of Physical Function and Exercise Capacity on the Outcomes In Hospitalized Elderly Patients with Acute Heart Failure

228. Registry of antithrombotic therapy in atrial fibrillation patients with bioprosthetic valves: A retrospective observational study

229. Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction

230. Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure

232. LONG-TERM CLINICAL OUTCOMES OF SEVERE TRICUSPID REGURGITATION WITHOUT LEFT-SIDE VALVE DISEASE

236. Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: an observational study

243. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

244. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

245. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

249. A decrease in tricuspid regurgitation pressure gradient associates with favorable outcome in patients with heart failure.

Catalog

Books, media, physical & digital resources